Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
about
The Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound HealingHyperhomocysteinemia as a Metabolic Risk Factor for Glucose Intolerance Among High-Risk Groups of Chinese AdultsFish oil and fenofibrate prevented phosphorylation-dependent hepatic sortilin 1 degradation in Western diet-fed mice.Atherosclerotic plaque formation and risk factors.Anthropometric measures and lipid coronary heart disease risk factors in Korean immigrants with type 2 diabetes.Insulin resistance induces posttranslational hepatic sortilin 1 degradation in mice.Understanding insulin resistance. What are the clinical implications?Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress.Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.Effect of a short-duration, culturally tailored, community-based diabetes self-management intervention for Korean immigrants: a pilot study.Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice.Perceptions of coronary heart disease risk in Korean immigrants with type 2 diabetesMetabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (prAlternative macrophage activation and metabolism.Increased CD36 protein as a response to defective insulin signaling in macrophagesUpregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes.The neointimal response to endovascular injury is increased in obese Zucker rats.Oats, antioxidants and endothelial function in overweight, dyslipidemic adults.Perceptions of risk of coronary heart disease among people living with type 2 diabetes mellitus.Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.Relation between insulin resistance and fast-migrating LDL subfraction as characterized by capillary isotachophoresis.
P2860
Q26827627-4379A3F7-00EB-4996-814E-7342ECBFDE73Q33797998-5F21CFB2-8783-496C-B138-3A3E88C3C394Q34070479-7DEE0824-FF8C-4BF3-85A1-24FFCABEE635Q35063770-863E949D-3981-43A3-99E3-FB0881D71578Q35109448-09AAFF71-E6D8-43A7-8516-AD862CC736B5Q35561045-51EE257E-7175-45A1-A07C-20E0A3D1BB19Q35845733-5715079C-A06F-4CE3-A452-148C83F037CAQ36204013-E0ED68D6-1527-4C91-A87C-AE02F9CE4621Q36675450-6771E714-B943-4D2B-AD09-022523C6ECC5Q36943713-39B81BC8-2641-40F7-ACCE-FF16E858590FQ37143361-A45005FB-9DF1-47C1-B5C4-55224B8B2AD3Q37157477-1CBEA043-B4C3-4DFB-8BBD-A81CBFBE8901Q37163044-0E1267E9-9029-431B-A51E-95094682C1B9Q37227312-46F78E8B-5B1E-4425-897D-4F6755FE0DD6Q37660996-F09A0CC1-2D5C-4B32-8775-1F56E1312B80Q37804862-D4700030-3D87-48AD-9485-5589A6A52A5EQ38344254-561BB3E9-8ABC-4809-8BC8-D84C45C80D12Q40156533-9E4D0557-728D-4B76-9601-0A8FF7ACE084Q44655646-33BED138-B15A-4BE0-8730-478DF97E0FB2Q45091940-EEB52724-B226-4D6F-98F0-62C99ADE54E5Q48336463-212C7E1B-2ADB-4389-A912-403310DC7ACEQ51737068-ACC4E116-DCB6-4AB5-BA04-A608926900DCQ53849228-67D7C88E-23FD-4D54-B86C-19F8CCB4E16A
P2860
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@ast
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@en
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@nl
type
label
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@ast
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@en
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@nl
prefLabel
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@ast
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@en
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@nl
P2860
P1476
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
@en
P2860
P356
10.1046/J.1462-8902.2001.00037.X
P478
P577
2002-01-01T00:00:00Z